Abstract
The majority of patients presenting with non-small cell lung cancer have disease that is either disseminated or too advanced locally for resection. The Radiation Therapy Oncology Group (RTOG) has demonstrated that high-dose conventional radiotherapy can improve local disease control.1 This has a favorable impact on long-term (not median) survival. Fast neutron radiotherapy is an innovative modality; the role of neutron treatment in improving local control for regional non-small cell lung cancer is being investigated.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
